NCT00663117View on ClinicalTrials.gov

The Effects of Naltrexone on Active Crohn's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions
InflammationCrohn's Disease
Interventions
DRUG

Naltrexone-HCl

naltrexone 4.5 mg

DRUG

Placebo

Placebo

Trial Locations (1)

17033

Penn State Hershey Medical Center, Hershey

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

collaborator

The Broad Foundation

OTHER

lead

Milton S. Hershey Medical Center

OTHER

NCT00663117 - The Effects of Naltrexone on Active Crohn's Disease | Biotech Hunter | Biotech Hunter